Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-Current Assets (2017 - 2021)

Historic Non-Current Assets for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $7.9 million.

  • Cogent Biosciences' Non-Current Assets rose 2211.03% to $7.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $26.6 million, marking a year-over-year decrease of 1178.93%. This contributed to the annual value of $6.0 million for FY2020, which is 3201.99% down from last year.
  • As of Q3 2021, Cogent Biosciences' Non-Current Assets stood at $7.9 million, which was up 2211.03% from $7.2 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Non-Current Assets registered a high of $11.4 million during Q1 2019, and its lowest value of $4.9 million during Q4 2018.
  • For the 5-year period, Cogent Biosciences' Non-Current Assets averaged around $7.5 million, with its median value being $7.1 million (2020).
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 9084.11% in 2019, then plummeted by 3484.76% in 2020.
  • Cogent Biosciences' Non-Current Assets (Quarter) stood at $6.7 million in 2017, then dropped by 26.89% to $4.9 million in 2018, then surged by 79.33% to $8.8 million in 2019, then tumbled by 32.02% to $6.0 million in 2020, then surged by 31.26% to $7.9 million in 2021.
  • Its Non-Current Assets stands at $7.9 million for Q3 2021, versus $7.2 million for Q2 2021 and $5.5 million for Q1 2021.